title: News studies: combining PROSTVAC with conventional cancer therapy.
authors.forename: Eva M
authors.initials: EM
authors.lastname: Riedmann
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D019496:Cancer Vaccines / Q000008:administration & dosage*; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008297:Male; D009942:Organometallic Compounds / Q000008:administration & dosage; D009943:Organophosphorus Compounds / Q000008:administration & dosage; D011471:Prostatic Neoplasms / Q000628:therapy*; D011878:Radiotherapy / Q000379:methods; D016032:Randomized Controlled Trials as Topic
chemical_list: D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D009942:Organometallic Compounds; D009943:Organophosphorus Compounds; C061972:samarium Sm-153 lexidronam